nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Irinotecan—lung cancer	0.296	0.654	CbGbCtD
Penicillamine—SLCO1B1—Methotrexate—lung cancer	0.157	0.346	CbGbCtD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.00599	0.115	CbGpPWpGaD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—UGT1A1—lung cancer	0.00563	0.108	CbGpPWpGaD
Penicillamine—L-Cysteine—GCLC—lung cancer	0.00483	1	CrCbGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—UGT1A1—lung cancer	0.0036	0.0688	CbGpPWpGaD
Penicillamine—SLCO1B1—Recycling of bile acids and salts—ABCC3—lung cancer	0.00344	0.0658	CbGpPWpGaD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.00328	0.0627	CbGpPWpGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—ABCG2—lung cancer	0.00312	0.0597	CbGpPWpGaD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.00305	0.0583	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of organic anions—AVP—lung cancer	0.00244	0.0466	CbGpPWpGaD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—ABCC3—lung cancer	0.0018	0.0344	CbGpPWpGaD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—AKR1C1—lung cancer	0.00174	0.0333	CbGpPWpGaD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.00167	0.0319	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of organic anions—ALB—lung cancer	0.00148	0.0282	CbGpPWpGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—APC—lung cancer	0.0014	0.0268	CbGpPWpGaD
Penicillamine—SLCO1B1—Recycling of bile acids and salts—ALB—lung cancer	0.0011	0.0209	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—lung cancer	0.000905	0.0173	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000815	0.0156	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000617	0.0118	CbGpPWpGaD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—ALB—lung cancer	0.000572	0.0109	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—lung cancer	0.000548	0.0105	CbGpPWpGaD
Penicillamine—Alopecia—Gemcitabine—lung cancer	0.000491	0.001	CcSEcCtD
Penicillamine—Hepatobiliary disease—Paclitaxel—lung cancer	0.00049	0.000999	CcSEcCtD
Penicillamine—Rash—Teniposide—lung cancer	0.000488	0.000996	CcSEcCtD
Penicillamine—Dermatitis—Teniposide—lung cancer	0.000488	0.000995	CcSEcCtD
Penicillamine—Tinnitus—Cisplatin—lung cancer	0.000483	0.000984	CcSEcCtD
Penicillamine—Lymphadenopathy—Methotrexate—lung cancer	0.000481	0.000981	CcSEcCtD
Penicillamine—Thrombocytopenia—Vinorelbine—lung cancer	0.000481	0.00098	CcSEcCtD
Penicillamine—Skin disorder—Vinorelbine—lung cancer	0.000477	0.000972	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000476	0.0091	CbGpPWpGaD
Penicillamine—Thrombophlebitis—Methotrexate—lung cancer	0.000474	0.000967	CcSEcCtD
Penicillamine—Urinary tract disorder—Etoposide—lung cancer	0.000468	0.000955	CcSEcCtD
Penicillamine—Anorexia—Vinorelbine—lung cancer	0.000468	0.000954	CcSEcCtD
Penicillamine—Pancytopenia—Docetaxel—lung cancer	0.000468	0.000953	CcSEcCtD
Penicillamine—Haemoglobin—Paclitaxel—lung cancer	0.000467	0.000953	CcSEcCtD
Penicillamine—Haemorrhage—Paclitaxel—lung cancer	0.000465	0.000948	CcSEcCtD
Penicillamine—Urethral disorder—Etoposide—lung cancer	0.000465	0.000948	CcSEcCtD
Penicillamine—Nausea—Teniposide—lung cancer	0.00046	0.000938	CcSEcCtD
Penicillamine—Neuropathy—Doxorubicin—lung cancer	0.00046	0.000937	CcSEcCtD
Penicillamine—Aplastic anaemia—Doxorubicin—lung cancer	0.00046	0.000937	CcSEcCtD
Penicillamine—Urinary tract disorder—Paclitaxel—lung cancer	0.000459	0.000936	CcSEcCtD
Penicillamine—Anaemia—Irinotecan—lung cancer	0.000459	0.000935	CcSEcCtD
Penicillamine—Alopecia—Cisplatin—lung cancer	0.000457	0.000932	CcSEcCtD
Penicillamine—Hepatic failure—Methotrexate—lung cancer	0.000457	0.000931	CcSEcCtD
Penicillamine—Urticaria—Topotecan—lung cancer	0.000456	0.00093	CcSEcCtD
Penicillamine—Urethral disorder—Paclitaxel—lung cancer	0.000456	0.000929	CcSEcCtD
Penicillamine—Body temperature increased—Topotecan—lung cancer	0.000454	0.000925	CcSEcCtD
Penicillamine—Body temperature increased—Erlotinib—lung cancer	0.000449	0.000915	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000447	0.000912	CcSEcCtD
Penicillamine—Anaemia—Gemcitabine—lung cancer	0.000447	0.000911	CcSEcCtD
Penicillamine—Leukopenia—Irinotecan—lung cancer	0.000444	0.000906	CcSEcCtD
Penicillamine—Mouth ulceration—Doxorubicin—lung cancer	0.000443	0.000903	CcSEcCtD
Penicillamine—Hypersensitivity—Vinblastine—lung cancer	0.000435	0.000888	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Methotrexate—lung cancer	0.000435	0.000887	CcSEcCtD
Penicillamine—Tinnitus—Paclitaxel—lung cancer	0.000433	0.000884	CcSEcCtD
Penicillamine—Leukopenia—Gemcitabine—lung cancer	0.000433	0.000882	CcSEcCtD
Penicillamine—Renal failure—Docetaxel—lung cancer	0.000431	0.00088	CcSEcCtD
Penicillamine—Neuropathy peripheral—Docetaxel—lung cancer	0.00043	0.000877	CcSEcCtD
Penicillamine—Angiopathy—Etoposide—lung cancer	0.00043	0.000877	CcSEcCtD
Penicillamine—Stomatitis—Docetaxel—lung cancer	0.000428	0.000872	CcSEcCtD
Penicillamine—Decreased appetite—Vinorelbine—lung cancer	0.000427	0.00087	CcSEcCtD
Penicillamine—Hypersensitivity—Topotecan—lung cancer	0.000423	0.000862	CcSEcCtD
Penicillamine—Angiopathy—Paclitaxel—lung cancer	0.000422	0.00086	CcSEcCtD
Penicillamine—Alopecia—Etoposide—lung cancer	0.000419	0.000854	CcSEcCtD
Penicillamine—Lymphadenopathy—Doxorubicin—lung cancer	0.000417	0.00085	CcSEcCtD
Penicillamine—Anaemia—Cisplatin—lung cancer	0.000416	0.000849	CcSEcCtD
Penicillamine—Hepatobiliary disease—Docetaxel—lung cancer	0.000415	0.000846	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000414	0.00791	CbGpPWpGaD
Penicillamine—Arthralgia—Gemcitabine—lung cancer	0.000412	0.000839	CcSEcCtD
Penicillamine—Alopecia—Paclitaxel—lung cancer	0.000411	0.000838	CcSEcCtD
Penicillamine—Thrombophlebitis—Doxorubicin—lung cancer	0.000411	0.000837	CcSEcCtD
Penicillamine—Agranulocytosis—Docetaxel—lung cancer	0.00041	0.000835	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Doxorubicin—lung cancer	0.000409	0.000833	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000409	0.000833	CcSEcCtD
Penicillamine—Mental disorder—Paclitaxel—lung cancer	0.000407	0.00083	CcSEcCtD
Penicillamine—Hepatic function abnormal—Doxorubicin—lung cancer	0.000407	0.000829	CcSEcCtD
Penicillamine—Diarrhoea—Vinblastine—lung cancer	0.000404	0.000824	CcSEcCtD
Penicillamine—Dysgeusia—Etoposide—lung cancer	0.000404	0.000824	CcSEcCtD
Penicillamine—Leukopenia—Cisplatin—lung cancer	0.000403	0.000822	CcSEcCtD
Penicillamine—Thrombocytopenia—Irinotecan—lung cancer	0.000397	0.000808	CcSEcCtD
Penicillamine—Dysgeusia—Paclitaxel—lung cancer	0.000396	0.000808	CcSEcCtD
Penicillamine—Haemoglobin—Docetaxel—lung cancer	0.000396	0.000807	CcSEcCtD
Penicillamine—Hepatic failure—Doxorubicin—lung cancer	0.000396	0.000807	CcSEcCtD
Penicillamine—Haemorrhage—Docetaxel—lung cancer	0.000394	0.000803	CcSEcCtD
Penicillamine—Diarrhoea—Topotecan—lung cancer	0.000393	0.000801	CcSEcCtD
Penicillamine—Urticaria—Vinorelbine—lung cancer	0.00039	0.000795	CcSEcCtD
Penicillamine—Urinary tract disorder—Docetaxel—lung cancer	0.000389	0.000793	CcSEcCtD
Penicillamine—Diarrhoea—Erlotinib—lung cancer	0.000389	0.000792	CcSEcCtD
Penicillamine—Body temperature increased—Vinorelbine—lung cancer	0.000388	0.000791	CcSEcCtD
Penicillamine—Urethral disorder—Docetaxel—lung cancer	0.000386	0.000788	CcSEcCtD
Penicillamine—Thrombocytopenia—Gemcitabine—lung cancer	0.000386	0.000788	CcSEcCtD
Penicillamine—Anorexia—Irinotecan—lung cancer	0.000386	0.000787	CcSEcCtD
Penicillamine—Skin disorder—Gemcitabine—lung cancer	0.000383	0.000781	CcSEcCtD
Penicillamine—Anxiety—Cisplatin—lung cancer	0.000382	0.000779	CcSEcCtD
Penicillamine—Anaemia—Etoposide—lung cancer	0.000381	0.000778	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000381	0.000777	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000377	0.000768	CcSEcCtD
Penicillamine—Anorexia—Gemcitabine—lung cancer	0.000376	0.000767	CcSEcCtD
Penicillamine—Vomiting—Vinblastine—lung cancer	0.000376	0.000766	CcSEcCtD
Penicillamine—Anaemia—Paclitaxel—lung cancer	0.000374	0.000763	CcSEcCtD
Penicillamine—Agitation—Paclitaxel—lung cancer	0.000372	0.000758	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.00037	0.000754	CcSEcCtD
Penicillamine—Leukopenia—Etoposide—lung cancer	0.000369	0.000753	CcSEcCtD
Penicillamine—Vomiting—Topotecan—lung cancer	0.000365	0.000744	CcSEcCtD
Penicillamine—Hypoglycaemia—Doxorubicin—lung cancer	0.000364	0.000743	CcSEcCtD
Penicillamine—Leukopenia—Paclitaxel—lung cancer	0.000362	0.000739	CcSEcCtD
Penicillamine—Rash—Topotecan—lung cancer	0.000362	0.000738	CcSEcCtD
Penicillamine—Hypersensitivity—Vinorelbine—lung cancer	0.000362	0.000738	CcSEcCtD
Penicillamine—Dermatitis—Topotecan—lung cancer	0.000362	0.000737	CcSEcCtD
Penicillamine—Vomiting—Erlotinib—lung cancer	0.000361	0.000736	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000361	0.0069	CbGpPWpGaD
Penicillamine—Thrombocytopenia—Cisplatin—lung cancer	0.00036	0.000734	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000359	0.000733	CcSEcCtD
Penicillamine—Rash—Erlotinib—lung cancer	0.000358	0.00073	CcSEcCtD
Penicillamine—Dermatitis—Erlotinib—lung cancer	0.000358	0.000729	CcSEcCtD
Penicillamine—Angiopathy—Docetaxel—lung cancer	0.000357	0.000729	CcSEcCtD
Penicillamine—Skin disorder—Cisplatin—lung cancer	0.000357	0.000728	CcSEcCtD
Penicillamine—Asthma—Methotrexate—lung cancer	0.000355	0.000723	CcSEcCtD
Penicillamine—Decreased appetite—Irinotecan—lung cancer	0.000352	0.000718	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—lung cancer	0.000351	0.000716	CcSEcCtD
Penicillamine—Nausea—Vinblastine—lung cancer	0.000351	0.000716	CcSEcCtD
Penicillamine—Anorexia—Cisplatin—lung cancer	0.00035	0.000715	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000349	0.000712	CcSEcCtD
Penicillamine—Alopecia—Docetaxel—lung cancer	0.000348	0.00071	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—lung cancer	0.000348	0.000709	CcSEcCtD
Penicillamine—Mental disorder—Docetaxel—lung cancer	0.000345	0.000704	CcSEcCtD
Penicillamine—Arthralgia—Paclitaxel—lung cancer	0.000345	0.000702	CcSEcCtD
Penicillamine—Anxiety—Paclitaxel—lung cancer	0.000343	0.0007	CcSEcCtD
Penicillamine—Decreased appetite—Gemcitabine—lung cancer	0.000343	0.000699	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000342	0.000698	CcSEcCtD
Penicillamine—Nausea—Topotecan—lung cancer	0.000341	0.000695	CcSEcCtD
Penicillamine—Nausea—Erlotinib—lung cancer	0.000337	0.000688	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—lung cancer	0.000337	0.000687	CcSEcCtD
Penicillamine—Diarrhoea—Vinorelbine—lung cancer	0.000336	0.000685	CcSEcCtD
Penicillamine—Dysgeusia—Docetaxel—lung cancer	0.000336	0.000685	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000335	0.000683	CcSEcCtD
Penicillamine—Thrombocytopenia—Etoposide—lung cancer	0.00033	0.000672	CcSEcCtD
Penicillamine—Skin disorder—Etoposide—lung cancer	0.000327	0.000667	CcSEcCtD
Penicillamine—Abdominal pain upper—Doxorubicin—lung cancer	0.000325	0.000662	CcSEcCtD
Penicillamine—Thrombocytopenia—Paclitaxel—lung cancer	0.000323	0.000659	CcSEcCtD
Penicillamine—Anorexia—Etoposide—lung cancer	0.000321	0.000655	CcSEcCtD
Penicillamine—Skin disorder—Paclitaxel—lung cancer	0.000321	0.000654	CcSEcCtD
Penicillamine—Body temperature increased—Irinotecan—lung cancer	0.00032	0.000653	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.00032	0.000653	CcSEcCtD
Penicillamine—Decreased appetite—Cisplatin—lung cancer	0.00032	0.000652	CcSEcCtD
Penicillamine—Anaemia—Docetaxel—lung cancer	0.000317	0.000646	CcSEcCtD
Penicillamine—Anorexia—Paclitaxel—lung cancer	0.000315	0.000642	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000314	0.006	CbGpPWpGaD
Penicillamine—Muscular weakness—Doxorubicin—lung cancer	0.000314	0.000639	CcSEcCtD
Penicillamine—Vomiting—Vinorelbine—lung cancer	0.000312	0.000637	CcSEcCtD
Penicillamine—Body temperature increased—Gemcitabine—lung cancer	0.000312	0.000636	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—lung cancer	0.000311	0.000634	CcSEcCtD
Penicillamine—Rash—Vinorelbine—lung cancer	0.00031	0.000631	CcSEcCtD
Penicillamine—Dermatitis—Vinorelbine—lung cancer	0.000309	0.000631	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—lung cancer	0.000308	0.000629	CcSEcCtD
Penicillamine—Asthma—Doxorubicin—lung cancer	0.000307	0.000626	CcSEcCtD
Penicillamine—Leukopenia—Docetaxel—lung cancer	0.000307	0.000626	CcSEcCtD
Penicillamine—Eosinophilia—Doxorubicin—lung cancer	0.000304	0.00062	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—lung cancer	0.000302	0.000615	CcSEcCtD
Penicillamine—Pancreatitis—Doxorubicin—lung cancer	0.000301	0.000614	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000301	0.000614	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—lung cancer	0.000299	0.00061	CcSEcCtD
Penicillamine—Hypersensitivity—Irinotecan—lung cancer	0.000298	0.000608	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—lung cancer	0.000295	0.000602	CcSEcCtD
Penicillamine—Decreased appetite—Etoposide—lung cancer	0.000293	0.000597	CcSEcCtD
Penicillamine—Arthralgia—Docetaxel—lung cancer	0.000292	0.000595	CcSEcCtD
Penicillamine—Pancytopenia—Doxorubicin—lung cancer	0.000292	0.000595	CcSEcCtD
Penicillamine—Nausea—Vinorelbine—lung cancer	0.000292	0.000595	CcSEcCtD
Penicillamine—Body temperature increased—Cisplatin—lung cancer	0.000291	0.000593	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00029	0.000591	CcSEcCtD
Penicillamine—Decreased appetite—Paclitaxel—lung cancer	0.000287	0.000585	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—lung cancer	0.000285	0.000582	CcSEcCtD
Penicillamine—Haemorrhage—Methotrexate—lung cancer	0.000284	0.000579	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000281	0.00536	CbGpPWpGaD
Penicillamine—Urinary tract disorder—Methotrexate—lung cancer	0.00028	0.000572	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—lung cancer	0.000278	0.000568	CcSEcCtD
Penicillamine—Diarrhoea—Irinotecan—lung cancer	0.000277	0.000565	CcSEcCtD
Penicillamine—Thrombocytopenia—Docetaxel—lung cancer	0.000274	0.000559	CcSEcCtD
Penicillamine—Skin disorder—Docetaxel—lung cancer	0.000272	0.000554	CcSEcCtD
Penicillamine—Hypersensitivity—Cisplatin—lung cancer	0.000271	0.000552	CcSEcCtD
Penicillamine—Diarrhoea—Gemcitabine—lung cancer	0.00027	0.00055	CcSEcCtD
Penicillamine—Renal failure—Doxorubicin—lung cancer	0.000269	0.000549	CcSEcCtD
Penicillamine—Neuropathy peripheral—Doxorubicin—lung cancer	0.000269	0.000548	CcSEcCtD
Penicillamine—Urticaria—Etoposide—lung cancer	0.000268	0.000546	CcSEcCtD
Penicillamine—Stomatitis—Doxorubicin—lung cancer	0.000267	0.000544	CcSEcCtD
Penicillamine—Anorexia—Docetaxel—lung cancer	0.000267	0.000544	CcSEcCtD
Penicillamine—Body temperature increased—Etoposide—lung cancer	0.000266	0.000543	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—lung cancer	0.000265	0.00054	CcSEcCtD
Penicillamine—Urticaria—Paclitaxel—lung cancer	0.000262	0.000535	CcSEcCtD
Penicillamine—Haematuria—Doxorubicin—lung cancer	0.000261	0.000533	CcSEcCtD
Penicillamine—Body temperature increased—Paclitaxel—lung cancer	0.000261	0.000532	CcSEcCtD
Penicillamine—Hepatobiliary disease—Doxorubicin—lung cancer	0.000259	0.000528	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—lung cancer	0.000258	0.000525	CcSEcCtD
Penicillamine—Vomiting—Irinotecan—lung cancer	0.000257	0.000525	CcSEcCtD
Penicillamine—Agranulocytosis—Doxorubicin—lung cancer	0.000256	0.000521	CcSEcCtD
Penicillamine—Rash—Irinotecan—lung cancer	0.000255	0.000521	CcSEcCtD
Penicillamine—Dermatitis—Irinotecan—lung cancer	0.000255	0.00052	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000255	0.00052	CcSEcCtD
Penicillamine—Diarrhoea—Cisplatin—lung cancer	0.000252	0.000513	CcSEcCtD
Penicillamine—Alopecia—Methotrexate—lung cancer	0.000251	0.000512	CcSEcCtD
Penicillamine—Vomiting—Gemcitabine—lung cancer	0.000251	0.000511	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—lung cancer	0.000249	0.000507	CcSEcCtD
Penicillamine—Rash—Gemcitabine—lung cancer	0.000249	0.000507	CcSEcCtD
Penicillamine—Dermatitis—Gemcitabine—lung cancer	0.000248	0.000507	CcSEcCtD
Penicillamine—Hypersensitivity—Etoposide—lung cancer	0.000248	0.000506	CcSEcCtD
Penicillamine—Haemoglobin—Doxorubicin—lung cancer	0.000247	0.000504	CcSEcCtD
Penicillamine—Haemorrhage—Doxorubicin—lung cancer	0.000246	0.000501	CcSEcCtD
Penicillamine—Decreased appetite—Docetaxel—lung cancer	0.000243	0.000496	CcSEcCtD
Penicillamine—Hypersensitivity—Paclitaxel—lung cancer	0.000243	0.000496	CcSEcCtD
Penicillamine—Urinary tract disorder—Doxorubicin—lung cancer	0.000243	0.000495	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—lung cancer	0.000242	0.000494	CcSEcCtD
Penicillamine—Urethral disorder—Doxorubicin—lung cancer	0.000241	0.000492	CcSEcCtD
Penicillamine—Nausea—Irinotecan—lung cancer	0.000241	0.00049	CcSEcCtD
Penicillamine—Nausea—Gemcitabine—lung cancer	0.000234	0.000478	CcSEcCtD
Penicillamine—Vomiting—Cisplatin—lung cancer	0.000234	0.000477	CcSEcCtD
Penicillamine—Rash—Cisplatin—lung cancer	0.000232	0.000473	CcSEcCtD
Penicillamine—Dermatitis—Cisplatin—lung cancer	0.000232	0.000472	CcSEcCtD
Penicillamine—Diarrhoea—Etoposide—lung cancer	0.00023	0.00047	CcSEcCtD
Penicillamine—Tinnitus—Doxorubicin—lung cancer	0.000229	0.000467	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—lung cancer	0.000229	0.000466	CcSEcCtD
Penicillamine—Diarrhoea—Paclitaxel—lung cancer	0.000226	0.000461	CcSEcCtD
Penicillamine—Angiopathy—Doxorubicin—lung cancer	0.000223	0.000455	CcSEcCtD
Penicillamine—Body temperature increased—Docetaxel—lung cancer	0.000221	0.000451	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—lung cancer	0.000221	0.000451	CcSEcCtD
Penicillamine—Nausea—Cisplatin—lung cancer	0.000218	0.000445	CcSEcCtD
Penicillamine—Alopecia—Doxorubicin—lung cancer	0.000217	0.000443	CcSEcCtD
Penicillamine—Mental disorder—Doxorubicin—lung cancer	0.000215	0.000439	CcSEcCtD
Penicillamine—Vomiting—Etoposide—lung cancer	0.000214	0.000437	CcSEcCtD
Penicillamine—Rash—Etoposide—lung cancer	0.000212	0.000433	CcSEcCtD
Penicillamine—Dermatitis—Etoposide—lung cancer	0.000212	0.000433	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—AZIN2—lung cancer	0.000212	0.00405	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—COL4A3BP—lung cancer	0.000212	0.00405	CbGpPWpGaD
Penicillamine—Arthralgia—Methotrexate—lung cancer	0.00021	0.000429	CcSEcCtD
Penicillamine—Vomiting—Paclitaxel—lung cancer	0.00021	0.000428	CcSEcCtD
Penicillamine—Dysgeusia—Doxorubicin—lung cancer	0.00021	0.000427	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000209	0.000426	CcSEcCtD
Penicillamine—Rash—Paclitaxel—lung cancer	0.000208	0.000425	CcSEcCtD
Penicillamine—Dermatitis—Paclitaxel—lung cancer	0.000208	0.000424	CcSEcCtD
Penicillamine—Hypersensitivity—Docetaxel—lung cancer	0.000206	0.000421	CcSEcCtD
Penicillamine—Nausea—Etoposide—lung cancer	0.0002	0.000408	CcSEcCtD
Penicillamine—Anaemia—Doxorubicin—lung cancer	0.000198	0.000403	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000198	0.00378	CbGpPWpGaD
Penicillamine—Thrombocytopenia—Methotrexate—lung cancer	0.000198	0.000403	CcSEcCtD
Penicillamine—Agitation—Doxorubicin—lung cancer	0.000197	0.000401	CcSEcCtD
Penicillamine—Nausea—Paclitaxel—lung cancer	0.000196	0.0004	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—lung cancer	0.000196	0.0004	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—AVP—lung cancer	0.000194	0.00371	CbGpPWpGaD
Penicillamine—Anorexia—Methotrexate—lung cancer	0.000192	0.000392	CcSEcCtD
Penicillamine—Leukopenia—Doxorubicin—lung cancer	0.000192	0.000391	CcSEcCtD
Penicillamine—Diarrhoea—Docetaxel—lung cancer	0.000192	0.000391	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000191	0.00366	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000188	0.00359	CbGpPWpGaD
Penicillamine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000184	0.000375	CcSEcCtD
Penicillamine—Arthralgia—Doxorubicin—lung cancer	0.000182	0.000372	CcSEcCtD
Penicillamine—Anxiety—Doxorubicin—lung cancer	0.000182	0.00037	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000181	0.000369	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—ATP5H—lung cancer	0.00018	0.00345	CbGpPWpGaD
Penicillamine—Vomiting—Docetaxel—lung cancer	0.000178	0.000363	CcSEcCtD
Penicillamine—Rash—Docetaxel—lung cancer	0.000177	0.00036	CcSEcCtD
Penicillamine—Dermatitis—Docetaxel—lung cancer	0.000176	0.00036	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—lung cancer	0.000175	0.000358	CcSEcCtD
Penicillamine—Thrombocytopenia—Doxorubicin—lung cancer	0.000171	0.000349	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GNG11—lung cancer	0.00017	0.00326	CbGpPWpGaD
Penicillamine—Skin disorder—Doxorubicin—lung cancer	0.00017	0.000346	CcSEcCtD
Penicillamine—Anorexia—Doxorubicin—lung cancer	0.000167	0.00034	CcSEcCtD
Penicillamine—Nausea—Docetaxel—lung cancer	0.000166	0.000339	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000166	0.00317	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PLBD1—lung cancer	0.000161	0.00307	CbGpPWpGaD
Penicillamine—Urticaria—Methotrexate—lung cancer	0.00016	0.000327	CcSEcCtD
Penicillamine—Body temperature increased—Methotrexate—lung cancer	0.00016	0.000325	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000159	0.000325	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000158	0.00302	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000153	0.00293	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000153	0.00293	CbGpPWpGaD
Penicillamine—Decreased appetite—Doxorubicin—lung cancer	0.000152	0.00031	CcSEcCtD
Penicillamine—Hypersensitivity—Methotrexate—lung cancer	0.000149	0.000303	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—HSD17B10—lung cancer	0.000147	0.00281	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—TF—lung cancer	0.000142	0.00272	CbGpPWpGaD
Penicillamine—Urticaria—Doxorubicin—lung cancer	0.000139	0.000283	CcSEcCtD
Penicillamine—Body temperature increased—Doxorubicin—lung cancer	0.000138	0.000282	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—lung cancer	0.000138	0.000281	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—CKB—lung cancer	0.000137	0.00261	CbGpPWpGaD
Penicillamine—Hypersensitivity—Doxorubicin—lung cancer	0.000129	0.000262	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—GSTM2—lung cancer	0.000128	0.00245	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CNDP2—lung cancer	0.000128	0.00245	CbGpPWpGaD
Penicillamine—Vomiting—Methotrexate—lung cancer	0.000128	0.000262	CcSEcCtD
Penicillamine—Rash—Methotrexate—lung cancer	0.000127	0.000259	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—lung cancer	0.000127	0.000259	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—MTMR3—lung cancer	0.000125	0.00239	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PGAM1—lung cancer	0.000122	0.00233	CbGpPWpGaD
Penicillamine—Nausea—Methotrexate—lung cancer	0.00012	0.000244	CcSEcCtD
Penicillamine—Diarrhoea—Doxorubicin—lung cancer	0.00012	0.000244	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—ALB—lung cancer	0.000118	0.00225	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP2A7—lung cancer	0.000116	0.00222	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SDC4—lung cancer	0.000114	0.00217	CbGpPWpGaD
Penicillamine—Vomiting—Doxorubicin—lung cancer	0.000111	0.000226	CcSEcCtD
Penicillamine—Rash—Doxorubicin—lung cancer	0.00011	0.000225	CcSEcCtD
Penicillamine—Dermatitis—Doxorubicin—lung cancer	0.00011	0.000224	CcSEcCtD
Penicillamine—Nausea—Doxorubicin—lung cancer	0.000104	0.000212	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—RRM1—lung cancer	0.000104	0.00198	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTA3—lung cancer	0.000104	0.00198	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—AVP—lung cancer	9.87e-05	0.00189	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—B4GALT5—lung cancer	9.73e-05	0.00186	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—lung cancer	9.56e-05	0.00183	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTA4—lung cancer	9.47e-05	0.00181	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	9.25e-05	0.00177	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTA2—lung cancer	9.23e-05	0.00176	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTA1—lung cancer	8.9e-05	0.0017	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ABCC3—lung cancer	8.8e-05	0.00168	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AKR1C1—lung cancer	8.53e-05	0.00163	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—UGT1A1—lung cancer	8.28e-05	0.00158	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GNG11—lung cancer	7.98e-05	0.00153	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	7.94e-05	0.00152	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALDOA—lung cancer	7.6e-05	0.00145	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—APOA1—lung cancer	7.55e-05	0.00144	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NCOA3—lung cancer	7.38e-05	0.00141	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.25e-05	0.00139	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ADCY1—lung cancer	7.18e-05	0.00137	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ABCG2—lung cancer	7.18e-05	0.00137	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HPGDS—lung cancer	7.04e-05	0.00135	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ENO2—lung cancer	7.04e-05	0.00135	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPP2R1B—lung cancer	6.99e-05	0.00134	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.9e-05	0.00132	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTT1—lung cancer	6.83e-05	0.0013	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GCLC—lung cancer	6.75e-05	0.00129	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP2A6—lung cancer	6.75e-05	0.00129	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.72e-05	0.00128	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ENO1—lung cancer	6.4e-05	0.00122	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—CREBBP—lung cancer	6.39e-05	0.00122	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.37e-05	0.00122	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.29e-05	0.0012	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ALB—lung cancer	5.98e-05	0.00114	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP2E1—lung cancer	5.74e-05	0.0011	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NQO1—lung cancer	5.67e-05	0.00108	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.55e-05	0.00106	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.5e-05	0.00105	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—RAF1—lung cancer	5.41e-05	0.00103	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—STK11—lung cancer	5.11e-05	0.000977	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.8e-05	0.000917	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTP1—lung cancer	4.73e-05	0.000904	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CAT—lung cancer	4.6e-05	0.00088	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.58e-05	0.000875	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ABCB1—lung cancer	4.48e-05	0.000856	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—TYMS—lung cancer	4.4e-05	0.000841	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTM1—lung cancer	4.35e-05	0.000831	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP1A1—lung cancer	4.12e-05	0.000788	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ERCC2—lung cancer	4.09e-05	0.000781	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—APOA1—lung cancer	3.54e-05	0.000676	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.39e-05	0.000647	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CG—lung cancer	3.23e-05	0.000617	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—POMC—lung cancer	3.07e-05	0.000587	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CREBBP—lung cancer	2.99e-05	0.000572	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CD—lung cancer	2.84e-05	0.000542	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALB—lung cancer	2.8e-05	0.000535	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CB—lung cancer	2.47e-05	0.000473	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PTGS2—lung cancer	2.45e-05	0.000468	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PTEN—lung cancer	2.14e-05	0.000409	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—EP300—lung cancer	2.04e-05	0.00039	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3CA—lung cancer	1.51e-05	0.000288	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AKT1—lung cancer	1.23e-05	0.000235	CbGpPWpGaD
